Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/29923
DC FieldValueLanguage
dc.contributor.authorAngelovska Petrushevska, Natalijaen_US
dc.contributor.authorMitreski, Nenaden_US
dc.contributor.authorAngelovska, Biljanaen_US
dc.contributor.authorKlisarovska, Violetaen_US
dc.contributor.authorAngelovski, Tomeen_US
dc.date.accessioned2024-04-08T06:25:35Z-
dc.date.available2024-04-08T06:25:35Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/29923-
dc.language.isoenen_US
dc.publisherOxford University Press on behalf of the European Society for Medical Oncologyen_US
dc.relation.ispartofAnnals of Oncology 2014en_US
dc.titleTrastuzumab in Her-2 positive advancd gastric carcinoma – long term survivorsen_US
dc.typeProceeding articleen_US
dc.relation.conferenceESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 25-28 June 2014.en_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Опис SizeFormat 
2014 ESMO.pdf69.16 kBAdobe PDFView/Open
Прикажи едноставен запис

Page view(s)

68
checked on 4.5.2025

Download(s)

10
checked on 4.5.2025

Google ScholarTM

Проверете


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.